BBL vs IPL: Is BroadBand Light Better Than a Standard Photofacial?

BBL — short for BroadBand Light — is Sciton's own brand of intense pulsed light, not a separate technology.

Sciton's history pages describe IPL itself emerging in the mid-1990s and Sciton developing its proprietary BroadBand Light pulsed-light technology from 2004.

The American Society of Plastic Surgeons (ASPS) defines intense pulsed light as a minimally invasive, non-laser light treatment that emits multiple wavelengths, which are absorbed and converted to heat, targeting pigment, blood vessels and hair follicles.

In ASPS's framing, BBL is a type of IPL, not a laser.

So the honest answer is that BBL is one manufacturer's IPL: every BBL device is an IPL device, while an "IPL photofacial" at a practice may be delivered with a Sciton BBL or with another maker's device — the general term names the light category, not the machine.

One naming issue cuts the other way: "photofacial" is a marketing name rather than a cleared indication, and IPL devices are 510(k)-cleared, not FDA-approved.

A documented example is Lumenis's Stellar M22, cleared in 2020 (K193500) with a 400–1200 nm spectrum and interchangeable filters — its cleared indications are in the table below.

BBL's differences from generic IPL are iterations inside one company's product line.

Sciton launched BBL HERO in 2020 and the current BBL HEROic in 2024, which it describes as adding motion tracking (its "Skin Positioning System"), automated pulse placement, and nine swappable wavelength filters across its JOULE and mJOULE platforms.

Speed is the headline of Sciton's own comparisons: the company says BBL HERO "proved to be up to 9X faster than other IPL devices" when considering fluences, spot sizes and repetition rates.

That figure is the manufacturer measuring its own device against others, so it is Sciton's claim rather than an independent benchmark.

The branded protocol is Forever Young BBL, Sciton's name for a BBL HEROic treatment protocol aimed at aging and sun damage — age spots, freckles, redness and small vessels.

Sciton says a session takes about 30 minutes, that patients feel warm for 30–60 minutes afterward, and that downtime is typically minimal.

The study behind the "Forever Young" concept is small, and it does not measure what the name implies.

In a 2013 Stanford pilot study (Chang, Bitter and colleagues, Journal of Investigative Dermatology), BBL treatment shifted the expression of 1,293 of 2,265 aging-associated RNAs toward a youthful pattern.

That is a gene-expression finding from a small pilot — not a measurement of visible results, and not evidence that BBL reverses aging.

A sourcing note, because it cuts both ways here: in the sources this page draws on, the IPL side rests on clearance documents and clinical studies, while the BBL side rests on Sciton's own published material and on that pilot.

Keep the asymmetry in mind when a practice quotes specific-sounding BBL numbers.

For the IPL side, published photorejuvenation data exist, with limits.

In a multicenter study of IPL photorejuvenation, 93 patients with Fitzpatrick type I–III skin had up to five full-face treatments at 4-week intervals, and wrinkle and elastosis scores improved in 82% of patients at 4 months and 75% at 6 months after the last treatment — an older study of light skin types only, with follow-up that ended at 6 months.

For sun spots specifically, a 2025 systematic review of solar lentigines — 41 trials, 3,234 patients — reported success rates of 74.6–90% for IPL, and found IPL and pulsed dye less associated with post-inflammatory hyperpigmentation than the treatments it compared.

Those are study-level ranges across many trials and devices, not what any one person will see.

On redness, the American Academy of Dermatology says IPL can reduce rosacea flushing and is gentler than a laser, but needs more sessions than laser therapy.

For BBL, the clinical evidence in the sources our research captured is the gene-expression pilot above, plus Sciton's own descriptions of its protocol targets.

Our research found no independent head-to-head trial comparing BBL with a standard IPL device, so no study crowns a winner between them.

Downtime comes from maker and study descriptions, not a standard chart.

Sciton says Forever Young BBL patients feel warm for 30–60 minutes afterward and that downtime is typically minimal.

For IPL, a 2019 study of 30 patients reported an average of 1.5 days of "social downtime" — but that protocol combined same-day IPL with a non-ablative fractional laser, so it is not IPL alone.

Ask the practice that operates your device what recovery they expect from their settings.

How long results last we could not confirm for either side: our research found no primary source for IPL photofacial longevity beyond study follow-ups of 4 to 6 months, and our read of Sciton's protocol page found no result duration stated — no maintenance frequency either.

None of the figures above is a promise — they are study outcomes, clearance language and maker statements for a licensed provider to interpret with you.

There is no national number to compare: our research found no current national average price for either treatment.

ASPS's 2025 Procedural Statistics Release does not report minimally invasive procedure counts or fees — it lists only the top five minimally invasive treatments by volume while it seeks a new data source — so no current ASPS average fee exists for IPL or BBL.

That gap applies to both sides of this comparison equally.

Session counts are where a bill grows: the multicenter photorejuvenation study used up to five full-face treatments, and Sciton describes Forever Young BBL as a protocol rather than a one-off.

With no national figure to benchmark against, the only price that means anything is the quote in front of you — collect several, and make them comparable with the list below.

There is no evidence-based winner to hand you.

No independent head-to-head trial of BBL against a standard IPL device came up in our research, and the makers' own comparisons — Sciton's speed claims above — are just that, the makers'. "Better" is answerable only for a specific face, a specific concern and a specific machine.

Start from the concern.

Sciton describes BBL HEROic's light modes as treating pigment, vascular and rosacea redness, mild-to-moderate inflammatory acne and hair removal; the example IPL clearance covers benign pigmented lesions, benign vascular lesions including facial telangiectasias and rosacea redness, scars and striae, and hair reduction.

The two columns overlap — pigment and redness appear in both — which is why the device name matters less than the examination behind the settings.

Skin type is a real filter on both sides.

Sciton says BBL HEROic's light modes treat Fitzpatrick types I–V, not VI, and describes only its SkinTyte infrared mode as usable on types V and VI.

On the IPL example, the device's hair-reduction clearance (K250809, 2025) claims permanent hair reduction only in Fitzpatrick types I–V (not VI), and our research read no skin-type list in its photorejuvenation indications — so how a device is set for your skin type is a question worth asking directly.

For the treatment-level detail on each side, the BBL photofacial guide and the IPL photofacial guide cover what sessions involve, what recovery looks like and how pricing is structured.

Whoever you book, the last step is the same: a licensed provider who examines your skin, names the exact device they will use, and puts the plan and the price in writing before you commit.